FEATURED

The $12.5 Trillion Demographic Wave Wall Street Keeps Mispricing

Start with a number that doesn’t get enough attention.

$12.5 trillion.

That is the annual economic output generated by Americans aged 50 and older, according to the AARP Longevity Economy Outlook 2026, published June 2026. Adults 50 and older drive enough economic activity annually to rank as the world’s third-largest economy, behind only the U.S. and China as a whole. That $12.5 trillion figure represented 43% of U.S. GDP in 2024, up from $8.3 trillion in 2018. And by 2060, as adults 50 and older come to represent 41% of the population (up from about 36% today), their economic contribution is expected to nearly double to $24 trillion.

Investors hear “aging demographics” and they think pharma. They think Medicare Advantage. They think GLP-1 drugs and hospital beds. That’s the first-order reflex, and it’s almost certainly already priced in.

Here’s what isn’t: where 123 million older Americans actually live, and what happens to those homes.

The House Is the Problem Nobody Is Solving

By 2030, one in five Americans will be 65 or older, and by 2034, older adults will outnumber children for the first time in U.S. history, according to Census Bureau projections. This year, the oldest baby boomers are turning 80.

And here’s the structural tension that makes this interesting from an investment standpoint: most of the existing U.S. housing stock was built for young families. Two-story layouts. Narrow doorways. Bathtubs with step-over thresholds. No stairlifts, no grab bars, no widened hallways. The housing industry only builds roughly one million new homes in a good year. There is simply not enough time, or supply, to build new accessible housing for all aging Americans at the pace the demographic is moving.

Now layer in the preference data. According to AARP surveys, 75% of adults aged 50 and older wish to age in place, and doing so often requires modifications that improve mobility, accessibility, and safety. Anyone who lives to age 65 will probably live to age 85, and because declining mobility typically begins in earnest as people reach their late 70s, many existing homes no longer support this demographic’s basic physical needs.

So the question isn’t whether this spending happens. It’s who captures it.

The Remodeling Surge Is Already Moving

The remodeling market is poised for growth in the coming years. Structural demand drivers including an aging housing stock, the persistent mortgage rate lock-in effect, and the trend for older homeowners to age in place are not going away, according to industry experts at the National Association of Home Builders (NAHB). That’s a rare thing in this market cycle: demand that doesn’t depend on rate cuts or GDP acceleration.

The NAHB Remodeling Market Index (RMI) came in at 61 in Q2 2026, solidly above the break-even level of 50. The RMI has registered above 50 for 24 consecutive quarters. An NAHB survey found that 56% of remodelers are involved in home modification work related to aging in place, and 73% of respondents indicated that requests for aging-in-place features have significantly or somewhat increased over the past five years.

NAHB is forecasting residential remodeling activity to increase 3% in 2026 and an additional 2% in 2027 in inflation-adjusted terms. That’s the broad market. The accessibility-specific slice is growing faster, driven by non-discretionary demand that does not ebb when consumer confidence dips.

Most investors see that and reach for the home improvement retailers. That’s still first-order thinking.

Slight tangent, but it matters: the mortgage rate lock-in effect is compounding this trend. Homeowners sitting on 3% mortgages are not selling. They are not moving into a more accessible single-story home and taking on a 7% rate. They are modifying their current homes. And as they age, those modifications get more specialized, more structural, and more expensive.

The Second Derivative Most People Skip

Here’s where it gets interesting.

Walk through the demand chain one more step. Bathroom remodel leads to bathroom accessibility upgrade, which leads to grab bars, walk-in showers, wider doorways, which leads to stairlifts, home elevators, platform lifts. Who makes those things?

As more adults aim to age in place, spending is shifting toward home modifications and safety upgrades that allow them to remain independent. Healthcare spending by Americans 50 and older reached $2.7 trillion in 2024 and is expected to more than double by 2060. The majority of older adults’ budgets are concentrated in healthcare, housing, and leisure — and those categories are converging at the home accessibility equipment level.

The home accessibility equipment market — stairlifts, residential elevators, platform lifts, patient-handling mobility systems — sits at the intersection of healthcare spending and home modification spending. The global stairlifts and climbing devices market alone was valued at approximately $2.8 billion in 2025 and is projected to reach $9.1 billion by 2036, growing at an 11.5% compound annual growth rate, according to Future Market Insights. In the U.S. specifically, the stairlift market reached $411.5 million in 2026 and is projected to grow at a 6.24% CAGR through 2031, according to Mordor Intelligence.

CNBC isn’t talking about this because there isn’t a single $500 billion company dominating the space. Bloomberg isn’t leading with it because it’s not an AI story. That’s precisely the point.

The actual beneficiary is two layers removed from the demographic headline.

The Company at the Bottleneck

Savaria Corporation (TSX: SIS) is a mid-cap Canadian company that most U.S. equity investors have never heard of. That is not an accident of quality. It’s an accident of geography and analyst coverage.

Savaria reported Q1 2026 revenue of $235.5 million, up $15.3 million or 7.0% year over year, driven by organic growth of 5.7% and a 0.7% contribution from acquisitions. The Accessibility segment — the core business — grew 7.9%. Gross profit came in at $91.7 million, representing 38.9% of revenue, an increase of 110 basis points compared to 37.8% in Q1 2025. Operating income was $33.0 million, up 55.3% year over year, representing a 14.0% operating margin compared to 9.6% in Q1 2025.

Adjusted EBITDA reached $48.1 million in Q1 2026, up 18.4% from $40.6 million in Q1 2025, representing a 20.4% EBITDA margin. Net earnings were $22.7 million, or $0.31 per diluted share, compared to $0.17 a year earlier — an 82% improvement in earnings per share. Cash from operations was $35.8 million for the quarter. Net debt stood at $178.7 million as of March 31, 2026, with a net debt to adjusted EBITDA ratio of 0.92x, down from 1.03x at year-end 2025.

At its April 2026 Investor Day, management outlined a five-year plan targeting approximately 12% annual revenue growth through 2030, driven by a mix of organic expansion and acquisitions. That would bring total revenue to roughly CAD $1.6 billion by end of 2030, with adjusted EBITDA margins held above 20% and adjusted EBITDA per share of approximately CAD $4.25.

The product line is straightforward: home elevators, stairlifts, platform lifts, vertical platform lifts, and patient-care mobility equipment for healthcare settings. The primary growth driver is non-discretionary demand from aging populations in North America and Europe — a demographic trend that provides a stable and growing end market regardless of macro conditions.

Non-discretionary. Think about what that means in a portfolio context. These aren’t aspirational purchases. When a 79-year-old can no longer safely climb the stairs, the stairlift isn’t optional.

Savaria’s business model includes recurring revenue from maintenance contracts, spare parts, and product upgrades. The company also pays a monthly dividend of CAD $0.0467 per share, yielding approximately 1.85% at current prices. That’s the kind of financial profile that tends to compound quietly while the rest of the market chases momentum plays.

The European Angle Nobody Is Modeling

Prior to acquiring Handicare in 2021, Savaria was heavily concentrated in North America. The Handicare transaction was a strategic move to gain significant market share and distribution across Europe, including key markets in the UK, Netherlands, and Germany, meaningfully balancing the company’s geographic revenue mix.

Management highlighted ongoing demand for accessibility products across both continents during the Q1 2026 earnings call, pointing to aging populations and home-modification trends as structural drivers that remain in place regardless of broader economic cycles.

Europe’s demographic curve is steeper than America’s. Germany, Italy, and Japan are already in the advanced stages of this transition. That’s not a near-term catalyst — it’s a runway extender. And most U.S.-focused investors are not modeling European accessibility equipment demand at all when they look at this space.

What Wall Street Is Missing

The consensus framing of the aging population trade is pharmaceutical. Novo Nordisk, AbbVie, Eli Lilly. Those are valid first-order plays, and they’re priced accordingly.

The second-order question — what happens to the homes these people are living in — is barely part of the institutional conversation. And the third-order question — who manufactures the physical equipment that makes those home modifications possible — is essentially invisible to the large-cap-focused equity research community.

Savaria’s stock has traded between CAD $19.41 and CAD $31.22 over the past 52 weeks, and as of early July 2026, SIS was trading near the top of that range at approximately CAD $30.91 with a market cap of roughly CAD $2.23 billion. The consensus analyst price target sits at approximately CAD $33.33, with multiple firms — including Scotiabank (target raised to CAD $33) and Stifel Nicolaus (maintaining Buy) — constructive on the name following Q1 results. Seven analysts currently rate the stock a Buy.

The company’s presence in both residential and institutional markets aligns with long-term structural trends in healthcare spending and home-modification activity, offering a niche industrial position that is less correlated with broad-market cyclicals. That’s the part that tends to get rewarded over a three-to-five-year horizon — not the company everyone’s watching, but the one sitting two derivatives deep in a trend that has nowhere to go but forward.

The Risk Picture

This isn’t a clean story without friction. Prolonged downturns in construction activity, Canadian dollar weakness against the U.S. dollar, and integration challenges from acquisitions are real risks. The TSX listing creates a currency dimension that U.S. investors need to account for. And elevated borrowing costs can dampen demand for higher-ticket residential elevator installations specifically.

The counter to those risks is structural: the primary demand driver — aging populations in North America and Europe — provides a stable and growing end market that does not depend on macro conditions improving. People do not stop aging because the Fed holds rates. The net debt to adjusted EBITDA ratio of 0.92x as of Q1 2026 suggests the balance sheet is in reasonable shape for continued execution.

Structured Trade Framework

Bull Case: Demographic demand accelerates as the oldest baby boomers turn 80 in 2026. Margin expansion continues as European integration matures toward the stated 20%+ EBITDA target. Management’s 12% annual revenue growth goal is achievable given structural demand. The stock moves toward the CAD $33+ analyst consensus target as U.S. institutional coverage expands and the valuation discount to U.S.-listed industrials compresses.

Bear Case: Housing market weakness extends broadly. Canadian dollar weakness persists and weighs on USD-denominated returns for U.S. investors. Acquisition integration creates unexpected margin drag. Accessibility segment organic growth slows below 5% annually, raising questions about the durability of the Q1 2026 EPS improvement.

Base Case: Revenue grows at 5 to 7% annually in line with consensus estimates. Margins hold near current levels around 20% adjusted EBITDA. The stock delivers moderate returns consistent with a defensive industrial compounder with a modest yield. No multiple expansion, but no contraction either. The demographic driver continues building underneath the surface.

For traders assessing exposure to the aging-in-place structural shift: A defined-risk approach to SIS involves monitoring the quarterly cadence of Accessibility segment organic growth as the primary indicator of whether the demographic demand is translating to durable top-line momentum. The Q2 2026 report will be the first meaningful test of whether the 82% EPS improvement in Q1 was a one-quarter event or the beginning of a multi-year re-rating cycle. Watch the EBITDA margin progression against the 20%+ target management laid out at Investor Day.

Options and Access Note

SIS trades on the Toronto Stock Exchange. U.S. investors seeking options exposure should note the TSX listing creates limitations for standard U.S.-listed options strategies. Direct equity ownership or exposure through Canadian-market accounts is the more practical approach for most. For U.S.-based portfolio construction, note that Savaria derives significant revenue from U.S. operations, where demand for home and commercial accessibility products is closely tied to the aging boomer cohort and federal and state-level accessibility standards — which gives domestic investors indirect economic exposure even without a U.S. listing.

The demographic clock is not a catalyst. It’s a constant. What makes it interesting as a position is the gap between how slowly the market recognizes structural demand and how quickly that demand actually materializes once the leading edge of the aging cohort hits the mobility threshold.

That gap is closing. The question is whether it closes before or after the stock moves.

Action Checklist

• Monitor Savaria Q2 2026 earnings for continued Accessibility segment organic growth above 5% and EBITDA margin progress toward the 20%+ target
• Track the NAHB Remodeling Market Index each quarter for confirmation of aging-in-place demand persistence; Q2 2026 reading of 61 remains constructive
• Watch for U.S. institutional initiations that would expand SIS’s investor base and potentially compress the relative valuation discount to U.S.-listed industrials
• Monitor CAD/USD quarterly for material currency headwinds or tailwinds on reported USD returns for U.S.-based investors
• Track European segment margin progression as Handicare integration matures toward the stated 20%+ adjusted EBITDA target
• All figures should be verified against current company filings and market data before any position is established

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.